row,column_idx,truth_value,llm_value,mismatch_value,llm_category
5,2,snrna-seq,scrna-seq,6,6
6,2,scrna-seq,rna-seq,6,6
9,2,scrna-seq; vdj-seq,scrna-seq,5,5
10,2,scrna-seq; vdj-seq,sctcr-seq,6,6
14,4,spleen,bone marrow,6,6
15,4,prostate,prostate cancer,4,4
16,4,prostate,prostate cancer,4,4
35,4,prostate carcinoma,prostate,3,3
36,4,prostate carcinoma,prostate,3,3
37,4,prostate carcinoma,prostate,3,3
38,4,prostate carcinoma,prostate,3,3
39,4,breast,breast tumor,4,4
40,4,breast,breast tumor,4,4
41,4,kidney,embryonic kidney,4,4
41,5,hek cells,hek-ter,4,4
42,4,kidney,embryonic kidney,4,4
42,5,hek cells,hek-ter,4,4
43,4,blood,bone marrow,6,6
44,4,blood,bone marrow,6,6
45,4,bone marrow,bone marrow microvascular niches (mvns),4,4
46,4,bone marrow,bone marrow microvascular niches (mvns),4,4
49,4,melanoma tumor sample/ skin?,skin,3,3
50,4,melanoma tumor sample/ skin?,skin,3,3
51,4,prostate,prostate cancer,4,4
52,4,prostate,prostate cancer,4,4
53,4,prostate,prostate cancer,4,4
54,4,prostate,prostate cancer,4,4
56,5,h1651,h1650,6,6
57,4,lymph nodes,draining lymph node,4,2
58,4,lymph nodes,draining lymph node,4,2
59,4,blood/ bone marrow,blood,5,5
59,5,hoxb8 cell,hoxb8,3,4
60,4,blood/ bone marrow,blood,5,5
60,5,hoxb8 cell,hoxb8,3,4
61,4,blood/ bone marrow,bone marrow,5,5
61,5,hoxb8 cell,no,6,6
62,4,blood/ bone marrow,bone marrow,5,5
62,5,hoxb8 cell,no,6,6
67,4,intestine,small intestine,4,3
68,4,intestine,small intestine,4,3
70,5,d459,d458,6,6
72,4,tumor inflitrating lymphocytes,blood,6,6
74,4,tumor inflitrating lymphocytes,blood,6,6
77,4,prostate,prostate cancer,4,4
78,4,prostate,prostate cancer,4,4
79,4,abdomen,abdominal wall tissue,4,4
80,4,splenocytes and lymph nodes,lymphocytes,6,6
81,4,splenocytes and lymph nodes,lymphocytes,6,6
82,5,myc-cap cells,myc-cap,3,2
83,5,myc-cap cells,myc-cap,3,2
85,5,tramp-c3,tramp-c2,6,6
86,5,myc-cap cells,myc-cap,3,2
87,5,myc-cap cells,myc-cap,3,2
88,5,myc-cap cells,myc-cap,3,2
89,5,myc-cap cells,myc-cap,3,2
92,5,kp cells,kp lung tumor cells,2,2
93,5,kp cells,kp lung tumor cells,2,2
94,3,mus musculus; synthetic construct,mus musculus,5,5
94,4,subcutaneously injected allograft tumor,subcutaneously injected tumor,3,2
94,5,,no,6,6
95,3,mus musculus; synthetic construct,mus musculus,5,5
95,4,subcutaneously injected allograft tumor,subcutaneously injected tumor,3,2
95,5,,no,6,6
97,4,prostate,prostate cancer,4,4
98,3,synthetic construct; homo sapiens and murine mouse model,homo sapiens,3,3
98,5,lncap/ar cells utilized to induce tumor in scid mice,lncap/ar,3,2
99,3,synthetic construct; homo sapiens and murine mouse model,homo sapiens,3,3
99,5,lncap/ar cells utilized to induce tumor in scid mice,lncap/ar,3,2
100,4,prostate,primary mouse prostate organoid culture,4,4
100,5,no. primary mouse prostate organoid culture,no,3,2
101,4,prostate,primary mouse prostate organoid culture,4,4
101,5,no. primary mouse prostate organoid culture,no,3,2
102,4,skin,skin tumor,4,4
104,5,no/ xenograft,pc3,6,6
105,4,prostate,prostate cancer,4,4
110,5,d458 cells,d458,3,2
111,5,d425 cells,d425,3,2
112,5,molm13 cells,molm13,3,2
113,5,molm13 cells,molm13,3,2
114,5,molm13 cells,molm13,3,2
115,5,molm13 cells,molm13,3,2
126,4,breast carcinoma,breast,3,3
127,4,breast carcinoma,breast,3,3
128,4,blood/plasma cell,bone marrow,6,6
129,4,multiple myeloma,bone marrow,6,6
134,4,brain,hippocampus,4,4
135,4,brain,hippocampus,4,4
136,4,lung,lung tumor,4,3
137,4,lung,lung tumor,4,3
137,5,no,b6al10,6,6
138,4,lung,lung tumor,4,3
139,4,lung,lung tumor,4,3
140,5,molm13 cells,molm13,3,2
144,5,no,cebpa/csf3r leukemia cells,6,6
145,5,no,cebpa/csf3r leukemia cells,6,6
146,5,no,cebpa/csf3r leukemia cells,6,6
147,5,no,cebpa/csf3r leukemia cells,6,6
148,4,lung,in vitro cultured cell line,6,6
149,5,h2009 cells,h2009,3,2
150,4,prostate,prostate cancer,4,4
150,5,lncap-ai (androgen independent),lncap-ai,2,2
151,4,prostate,prostate cancer,4,4
151,5,du145 cells,du145,3,2
152,4,prostate,normal prostate,6,4
153,4,prostate,normal prostate,6,4
154,5,pc3 cells,pc3,3,2
155,5,pc3 cells,pc3,3,2
156,4,prostate,prostate epithelium-derived cells,4,4
157,4,prostate,prostate epithelium-derived cells,4,4
158,5,m3 cell line derived mouse allograft,no,6,6
159,5,m3 cell line derived mouse allograft,m3,3,2
166,4,ovary,ovarian cancer,4,2
166,5,ocvar3 cells,ovcar3,2,2
167,4,ovary,ovarian cancer,4,2
167,5,ocvar3 cells,ovcar3,2,2
170,4,blood,monocyte-derived macrophages,6,6
171,4,blood,monocyte-derived macrophages,6,6
172,4,breast,breast tumor,4,4
173,4,breast,breast tumor,4,4
174,4,lymph nodes,draining lymph node,4,2
175,4,lymph nodes,lymph node,2,2
177,4,prostate,prostate cancer,4,4
177,5,lncap,lncap-rb1/tp53 double knockout,4,4
179,4,large intestine,colon cancer,6,4
180,4,prostate,prostate cancer,4,4
181,4,prostate,prostate cancer,4,4
182,4,bone marrow aspirates,bone marrow,3,3
183,4,bone marrow aspirates,bone marrow,3,3
184,2,plumage,merip-seq,6,6
184,5,hek293 t,hek293t,2,2
185,2,plumage,merip-seq,6,6
185,5,hek293 t,hek293t,2,2
186,4,esophagus,adjacent normal esophageal tissue,4,4
187,4,esophagus,esophageal squamouse carcinoma,4,4
188,4,esophagus,esophageal squamouse carcinoma,4,4
189,4,esophagus,adjacent normal esophageal tissue,4,4
190,2,cite-seq,scrna-seq,6,6
190,4,bladder,bladder tissue,4,2
191,2,cite-seq,scrna-seq,6,6
191,4,bladder,bladder tissue,4,2
192,4,umbilical vein endothelium,blood,6,6
192,5,no,primary human umbilical vein endothelial cells,6,6
193,4,umbilical vein endothelium,blood,6,6
193,5,no,primary human umbilical vein endothelial cells,6,6
194,4,unclear,prostate,6,6
195,4,unclear,bone,6,6
196,4,esophagus,esophageal epithelium,4,4
197,4,esophagus,esophageal squamous carcinoma,4,4
197,5,ec-109,no,6,6
198,4,umbilical vein endothelium,blood,6,6
198,5,no,primary human umbilical vein endothelial cells,6,6
199,4,umbilical vein endothelium,blood,6,6
199,5,no,primary human umbilical vein endothelial cells,6,6
200,4,breast,breast cancer,4,4
201,4,breast,breast cancer,4,4
202,2,rna-seq,scrna-seq,6,6
202,4,mouth/ oral cavity,tumor,6,3
202,5,moc1,no,6,6
203,4,mouth/ oral cavity,tumor,6,3
203,5,moc1,no,6,6
210,4,sub cutaneous tumors (xenograft),cd45+ tumor infiltrating cells,6,6
211,4,sub cutaneous tumors (xenograft),cd45+ tumor infiltrating cells,6,6
214,4,breast,breast tumor,4,4
215,4,breast,breast tumor,4,4
216,2,"scbcr-seq
          ",scrna-seq,6,6
216,4,ovary,ovarian tumor,4,3
217,2,"scbcr-seq
          ",scrna-seq,6,6
217,4,ovary,ovarian tumor,4,3
223,5,oci-aml2 cells,oci-aml2,3,2
224,5,oci-aml2 cells,oci-aml2,3,2
225,4,lung,small cell lung cancer,4,4
225,5,hci- h69,nci-h69,3,6
226,4,lung,small cell lung cancer,4,4
229,2,clint-seq  (mrna sequencing via crosslinker regulated intracellular phenotype),sctcr-seq,6,6
230,2,clint-seq  (mrna sequencing via crosslinker regulated intracellular phenotype),sctcr-seq,6,6
233,4,pancreas,pancreatic ductal adenocarcinoma,4,4
234,4,pancreas,pancreatic ductal adenocarcinoma,4,4
235,4,lung,lung adenocarcinoma,4,4
236,4,lung,lung adenocarcinoma,4,4
247,4,soft tissue/ bone,lung,6,6
248,4,soft tissue/ bone,soft-tissue sarcoma,4,4
249,4,soft tissue/ bone,immune-enriched cells from subcutaneous tumors,6,6
250,4,soft tissue/ bone,immune-enriched cells from subcutaneous tumors,6,6
255,4,stomach,gastric organoids,4,4
256,4,stomach,gastric organoids,4,4
257,4,intestine,colon,4,2
258,4,intestine,proximal small intestine,4,4
259,4,intestine,colon,4,2
260,4,intestine,colon,4,2
271,2,rna-seq/ plumage,rna-seq,5,5
275,4,lymph nodes,patient derived xenograft,6,6
275,5,no,mcl96069,6,6
276,4,lymph nodes,patient derived xenograft,6,6
276,5,no,mcl96069,6,6
277,4,prostate,prostate epithelial cell line,4,4
278,4,prostate,prostate epithelial cell line,4,4
279,2,bisulfite-seq/ methyl-capture,methylc-seq,5,2
279,4,prostate,prostate epithelial cell line,4,4
280,2,bisulfite-seq/ methyl-capture,methylc-seq,5,2
280,4,prostate,prostate epithelial cell line,4,4
281,4,prostate,prostate epithelial cell line,4,4
282,4,prostate,prostate epithelial cell line,4,4
283,2,exome-seq,other,6,6
283,4,prostate,prostate cancer,4,4
283,5,pdx derived from lucap series 23 cells,no,6,6
284,2,exome-seq,other,6,6
284,4,prostate,prostate cancer,4,4
284,5,pdx derived from lucap series 23 cells,no,6,6
287,4,intestine,intestinal tissue,2,2
288,4,intestine,intestinal tissue,2,2
292,5,387,glioblastoma stem cell line 387,4,4
297,4,blood,whole blood,4,2
298,4,blood,whole blood,4,2
301,4,prostate xenograft,prostate,3,3
301,5,primary xenograft cwr22,cwr22,3,3
302,4,prostate xenograft,prostate,3,3
302,5,primary xenograft cwr22,cwr22,3,3
303,4,prostate xenograft,prostate,3,3
303,5,primary xenograft cwr22,cwr22 xenograft,3,2
304,4,prostate xenograft,prostate,3,3
304,5,primary xenograft cwr22,cwr22 xenograft,3,2
305,4,peripheral nervous system,nerve sheath,4,3
305,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
306,4,peripheral nervous system,nerve sheath,4,3
306,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
307,4,peripheral nervous system,nerve sheath,4,3
307,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
308,4,peripheral nervous system,nerve sheath,4,3
308,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
309,4,peripheral nervous system,nerve sheath,4,3
309,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
310,4,peripheral nervous system,nerve sheath,4,3
310,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
311,4,lung,primary lung tumor,4,2
312,4,lung,primary lung tumor,4,2
313,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
314,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
315,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
316,5,lncap-c42 (ar therapy resistant),lncap,3,4
317,4,blood/ spleen,blood,5,5
320,5,waga cells,waga,3,2
321,5,waga cells,waga,3,2
326,4,prostate,prostate cancer organoid,4,4
328,4,pancreas,pancreatic ductal adenocarcinoma,4,4
328,5,aspc1,aspc-1,2,2
329,4,pancreas,pancreatic ductal adenocarcinoma,4,4
329,5,aspc1,aspc-1,2,2
330,2,rna-seq; scrna-seq; atac-seq; cut&tag; cut&run,crispr-seq,6,6
330,5,kasumi-1 cells,kasumi-1,3,2
331,2,rna-seq; scrna-seq; atac-seq; cut&tag; cut&run,rna-seq,5,5
331,5,no,14-00613,6,6
337,4,colon/ large intestine,colon,5,2
338,4,colon/ large intestine,colon,5,2
339,4,colon/ large intestine,colon,5,2
342,4,bladder,bladder cancer,4,4
343,4,bladder,bladder cancer,4,4
345,2,rna-seq;,rna-seq,2,2
346,5,kasumi-1 cells,kasumi-1,3,2
347,5,kasumi-1 cells,kasumi-1,3,2
348,4,bladder xenograft,bladder cancer,4,2
348,5,no,t24,6,6
349,4,bladder xenograft,bladder,3,3
349,5,no,t24,6,6
352,4,intestine,intestinal stem cells and progenitor cells,4,4
353,4,intestine,intestinal stem cells and progenitor cells,4,4
354,4,ovary,ovarian tumor,4,3
355,2,scrna-seq; scatac-seq,scrna-seq,5,5
355,4,ovary,ovarian tumor,4,3
356,4,prostate/ bone metastasis,prostate cancer,5,5
356,5,pc3e (pc3 cells sorted for e-cadherin-positive cells ),pc3e,3,2
360,5,no/ induced pluripotent cells,no,3,6
361,5,no/ induced pluripotent cells,no,3,6
362,4,blood,pbc,6,6
363,4,blood,pbc,6,6
364,4,prostate xenograft,prostate cancer tumor,4,2
365,4,prostate xenograft,prostate cancer tumor,4,2
366,4,lung,"lung tissue, archival ffpe",4,4
367,4,lung,"lung tissue, archival ffpe",4,4
368,2,cite-seq,sctcr-seq,6,6
369,2,cite-seq,sctcr-seq,6,6
370,4,ovary,ovarian tumor,4,3
371,4,ovary,ovarian tumor,4,3
374,4,prostate,prostate cancer,4,4
375,4,prostate,prostate cancer,4,4
376,5,msk-pca3,no,6,6
377,5,msk-pca3,no,6,6
378,4,blood,peripheral blood,4,2
379,4,blood,peripheral blood,4,2
386,4,prostate,prostate cancer,4,4
387,4,prostate,prostate cancer,4,4
390,4,prostate,prostate cancer,4,4
391,4,prostate,prostate cancer,4,4
392,4,bladder,bladder tumor,4,4
393,4,bladder,bladder tumor,4,4
394,4,bladder,bladder cancer,4,4
395,4,bladder,bladder cancer,4,4
396,4,spleen,no,6,6
397,4,spleen,hematopoietic system,3,6
400,4,blood,in vitro t cell culture,6,6
401,4,blood,in vitro t cell culture,6,6
404,5,mouse lung squamous cell carcinoma cell line,lung squamous cell carcinoma cell line,2,2
405,2,cut&tag-seq,cut&tag,2,6
405,5,mouse lung squamous cell carcinoma cell line,lung squamous cell carcinoma cell line,2,2
410,4,prostate,prostate cancer patient derived xenograft,4,4
410,5,no,lucap 78,6,6
411,4,prostate,prostate cancer patient derived xenograft,4,4
411,5,no,lucap 77,6,6
414,4,pancrease,pancreatic ductal adenocarcinoma,4,4
415,4,pancrease,pancreatic ductal adenocarcinoma,4,4
416,4,human glioblastoma pdx models,brain,3,3
417,4,human glioblastoma pdx models,brain,3,3
418,4,liver,liver tumor biopsy,4,4
419,2,cite-seq,scrna-seq,6,6
421,4,subcutaneous tumor tissue (flank),tumor,3,3
422,4,subcutaneous tumor tissue (flank),tumor,3,3
423,2,cite-seq,scrna-seq,6,6
424,2,cite-seq,scrna-seq,6,6
425,4,extrahepatic cholangiocarcinoma,bile duct,6,3
426,4,intrahepatic cholangiocarcinoma,bile duct,6,3
433,4,prostate,gemm,6,6
435,4,subcutaneous tumor,s.c. tumor,2,2
435,5,mc38,no,6,6
436,4,subcutaneous tumor,s.c. tumor,2,2
436,5,mc38,no,6,6
437,4,blood,peripheral blood mononuclear cells,4,4
438,4,blood,peripheral blood mononuclear cells,4,4
439,4,blood / bone marrow,blood,5,5
440,4,blood / bone marrow,blood,5,5
454,4,breast,breast cancer,4,4
459,4,bone marrow,blood,6,6
463,4,blood,whole blood,4,2
464,4,blood,whole blood,4,2
465,2,crispr-cas9 sgrna screen,crispr-seq,3,6
467,4,breast,breast cancer,4,4
468,4,breast,breast cancer,4,4
473,4,breast,breast cancer,4,4
474,4,breast,breast cancer,4,4
475,4,peritoneal fluid,blood,6,6
476,4,peritoneal fluid,blood,6,6
478,4,prostate,prostate cancer,4,4
483,5,pymt,no,6,6
484,5,pymt,no,6,6
485,2,cite-seq,sctcr-seq,6,6
486,2,cite-seq,sctcr-seq,6,6
493,4,colon tumor,colon,3,3
494,4,colon tumor,colon,3,3
498,4,prostate ,prostate cancer,4,4
499,4,kidney,renal cell carcinoma,4,4
500,4,kidney,renal cell carcinoma,4,4
501,4,kidney,renal cell carcinoma,4,4
502,4,kidney,renal cell carcinoma,4,4
505,4,tubular adenoma,colon,3,3
506,4,tubular adenoma,colon,3,3
509,4,bone marrow,bone marrow cells,4,4
510,4,bone marrow,bone marrow cells,4,4
511,4,tongue epithelium,squamous cell carcinoma,6,4
512,4,tongue epithelium,squamous cell carcinoma,6,4
519,2,rna-seq,scrna-seq,6,6
521,4,breast,breast tumor,4,4
522,4,breast,breast tumor,4,4
523,5,primary mouse mammary fibroblasts ,primary mouse mammary fibroblasts line,2,2
524,5,primary mouse mammary fibroblasts,primary mouse mammary fibroblasts line,2,2
525,4,breast,mammary fat pad,4,6
526,4,breast,mammary fat pad,4,6
533,4,skin,solid tumor,6,3
534,4,skin,solid tumors,6,3
535,4,skin,solid tumors,6,3
536,2, crispr screen,crispr-seq,6,2
536,5,trametinib resistant molm13,molm-13,3,2
537,2,crispr screen,crispr-seq,6,2
537,5,trametinib resistant molm13,molm-13,3,2
540,4,bone marrow,bone marrow plasma cells,4,4
541,4,bone marrow,bone marrow plasma cells,4,4
542,4,bone marrow,primary dendritic cells,6,6
543,4,bone marrow,primary dendritic cells,6,6
544,4,bone marrow,primary dendritic cells,6,6
545,4,bone marrow,primary dendritic cells,6,6
546,4,pancreas,pancreatic tumor,4,4
547,4,pancreas,pancreatic tumor,4,4
550,4,in vitro–differentiated cd8⁺ t cells from hpscs,blood,6,6
550,5,"esi017 tko8 eso hpsc (rag1/rag2/b2m triple knockout, tcr-transduced)",no,6,6
551,4,in vitro–differentiated cd8⁺ t cells from hpscs,blood,6,6
551,5,esi017 wt hpsc,no,6,6
570,5,jjn-3,jjn3,2,2
571,5,jjn-3,jjn3,2,2
575,4,colon,colon carcinoma,4,4
576,4,embryo,mesenchyme,4,6
577,4,embryo,mesenchymal stem cell,4,6
590,5,rpm rr112,no,6,6
591,4,periaortic lymph node met,prostate,6,6
591,5,rpm rr112,no,6,6
592,2,snrna-seq,scrna-seq,6,6
592,5,rpm rr112,no,6,6
601,4,lung,"lung tissue, archival ffpe",4,4
602,4,lung,"lung tissue, archival ffpe",4,4
605,4,prostate,tissue,6,3
606,4,prostate,tissue,6,3
611,4,tongue,head and neck,6,3
612,4,tongue,hnscc,3,6
613,4,head and neck,tumor,3,3
614,4,head and neck,tumor,3,3
615,2,rna-seq,scrna-seq,6,6
616,2,rna-seq,scrna-seq,6,6
628,4, ,kidney,6,3
629,4,prostate,prostate tumor,4,4
630,4,prostate,prostate tumor,4,4
631,5,myc-cap,no,6,6
633,4,prostate organoid,mouse prostate organoid,4,4
634,4,prostate organoid,mouse prostate organoid,4,4
639,4,prostate,prostate cancer,4,4
640,4,prostate,prostate cancer,4,4
641,4,breast,breast cancer tissue,4,4
642,4,breast,breast cancer tissue,4,4
645,4,prostate,"prostate tumor, lymph node",4,5
646,4,prostate,"prostate tumor, primary",4,4
649,2,rna-seq,scrna-seq,6,6
650,2,rna-seq,scrna-seq,6,6
651,4,lymph node ,lymph node metastasis,4,4
656,4,ovarian cancer,ovarian tumor,2,2
657,2,crispr screen,crispr-seq,6,2
657,4,soft tissue,synovial sarcoma,4,4
657,5,hs-sy-ii cas9,hs-sy-ii,3,2
658,2,crispr screen,crispr-seq,6,2
658,4,soft tissue,synovial sarcoma,4,4
658,5,hs-sy-ii cas9,hs-sy-ii,3,2
659,4,soft tissue,synovial sarcoma,4,4
660,4,soft tissue,synovial sarcoma,4,4
661,4,soft tissue,synovial sarcoma,4,4
662,4,soft tissue,synovial sarcoma,4,4
663,4,soft tissue,synovial sarcoma,4,4
664,4,soft tissue,synovial sarcoma,4,4
665,4,bone marrow,human bone marrow biopsy,4,4
668,5,n6_4172,no,6,6
669,2,cut&tag,cut&tag-seq,2,2
669,5,ey,no,6,6
670,2,cut&tag,cut&tag-seq,2,2
670,5,ey,no,6,6
671,5,eyh2_4028,no,6,6
672,4,tongue epithelium,tongue epithelium primary culture,4,4
672,5,n2_4172,no,6,6
673,4,tongue?,tongue epithelium,4,4
677,4,pancreas,primary pancreatic ductal adenocarcinoma,4,4
678,4,pancreas,primary pancreatic ductal adenocarcinoma,4,4
684,2,scrna-seq,scmultiome,6,6
687,4,lung,lung adenocarcinoma,4,4
688,4,lung,lung adenocarcinoma,4,4
691,4,breast,ffpe,6,6
692,4,breast,ffpe,6,6
693,4,kidney,embryonic kidney,4,4
694,4,kidney,embryonic kidney,4,4
701,4,gastrointestinal tract,gastrointestinal stromal tumor,4,4
702,4,gastrointestinal tract,gastrointestinal stromal tumor,4,4
709,4,prostate,prostate cancer,4,4
710,4,prostate,prostate cancer,4,4
711,4,prostate,prostate cancer,4,4
712,4,prostate,prostate cancer,4,4
713,4,prostate,prostate cancer,4,4
714,4,prostate,prostate cancer,4,4
717,4,prostate,prostate cancer,4,4
718,4,prostate,prostate cancer,4,4
725,2,qrt-pcr array,rt-pcr,3,2
725,5,tramp-c2,no,6,6
726,2,qrt-pcr array,rt-pcr,3,2
726,5,tramp-c2,no,6,6
727,4,lung,non-small cell lung cancer cells,4,4
728,4,lung,non-small cell lung cancer,4,4
729,4,lung,non-small cell lung cancer,4,4
730,4,lung,non-small cell lung cancer,4,4
735,4,prostate,prostate cancer,4,4
736,4,prostate,prostate cancer,4,4
